サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786721

ハイドロゲルをベースとしたドラッグデリバリーシステムの世界市場

Hydrogel-based Drug Delivery Systems

出版日
ページ情報
英文 290 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
ハイドロゲルをベースとしたドラッグデリバリーシステムの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 290 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ハイドロゲルをベースとしたドラッグデリバリーシステムの世界市場は2030年までに216億米ドルに達する見込み

2024年に153億米ドルと推定されるハイドロゲルをベースとしたドラッグデリバリーシステムの世界市場は、2024年から2030年にかけてCAGR 5.9%で成長し、2030年には216億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである天然は、CAGR6.1％を記録し、分析期間終了までに123億米ドルに達すると予想されます。合成セグメントの成長率は、分析期間中CAGR 5.9％と推定されます。

米国市場は42億米ドルと推定、中国はCAGR 9.3％で成長予測

米国のハイドロゲルをベースとしたドラッグデリバリーシステム市場は、2024年には42億米ドルになると推定されます。世界第2位の経済大国である中国は、2030年までに44億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9%と5.8%と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界のハイドロゲルをベースとしたドラッグデリバリーシステム市場- 主要動向と促進要因まとめ

ハイドロゲルベースシステムが現代のドラッグデリバリーにおけるゲームチェンジャーとなる理由とは？

ハイドロゲルをベースとしたドラッグデリバリーシステムは、精密医療の進化の礎石として登場し、制御された標的治療デリバリーのための高度なプラットフォームを提供しています。これらの親水性ポリマー・ネットワークは、その生体適合性、高い含水率、自然の組織環境を模倣した調整可能な物理的特性により珍重されています。重要な差別化要因は、pH、温度、酵素などの様々な生理学的刺激に応答する能力にあり、これにより部位特異的な薬物放出と治療効果の向上が可能になります。近年、スマートハイドロゲルやナノコンポジットハイドロゲルのような新しいハイドロゲル製剤は、特に腫瘍、眼科、創傷治療用途において、薬物の保持時間や反応性を改善するように設計されてきました。このイノベーション主導のセクターは、治療のパラダイムを再構築し、個別化された低侵襲で効率的な治療オプションを提供しています。

バイオメディカル用途急増の触媒はイノベーションか？

ハイドロゲルはドラッグデリバリーにとどまらず、幅広い医療応用分野で有用性を見出しており、ヘルスケア分野における戦略的価値を高めています。組織工学的足場、再生医療、診断システムなどにおけるハイドロゲルの使用は、その多様性を浮き彫りにしています。特に、注射用ハイドロゲルは、全身への曝露を最小限に抑え、局所的で持続的なドラッグデリバリーを提供することで、手術後の回復や慢性疾患の管理に革命をもたらしています。この進歩はがん治療において顕著であり、ハイドロゲルは腫瘍部位への化学療法剤の直接送達を容易にし、毒性を軽減します。さらに、ハイドロゲル技術とバイオエレクトロニック・デバイスの統合は、リアルタイムの治療フィードバック・システムを可能にし、個別化医療における診断と治療の架け橋となっています。このような分野横断的な応用により、ハイドロゲル技術は医療革新の主流へと押し上げられつつあります。

規制と調査のエコシステムはどのように市場の軌道を形成しているか？

支持的な規制の道筋と強力な研究イニシアチブは、ハイドロゲルをベースとしたドラッグデリバリーシステムの商業的可能性を大幅に加速しています。ハイドロゲル製剤を改良し、生物製剤、ペプチド、遺伝子治療との相乗的利用を探るため、世界的に政府および学術機関の研究開発投資が増加しています。FDAの生体材料承認に対する柔軟な姿勢は、新興企業や製薬大手がリードタイムを短縮して新しいハイドロゲルシステムを市場に投入する道をさらに開いています。さらに、この分野での特許活動は増加傾向にあり、臨床研究中のハイドロゲル有効治療薬の強力なパイプラインがあります。これと並行して、産学連携によるイノベーションのエコシステムが、特に北米とアジア太平洋で醸成されつつあり、これらの地域は先進的なハイドロゲル技術開発のホットスポットとなりつつあります。これらの要因は、製品パイプラインを充実させるだけでなく、プロセスの最適化とスケーラビリティによってコスト削減にもつながっています。

なぜ複数の治療フロンティアで市場拡大が加速しているのか？

ハイドロゲルをベースとしたドラッグデリバリーシステム市場の成長は、技術の進歩、使用事例の拡大、消費者の期待の変化を反映したいくつかの要因によって牽引されています。患者中心の非侵襲的治療法に対する需要の高まりは、局所的かつ持続的な薬物投与におけるハイドロゲルの能力と一致しています。ハイドロゲルマトリックスの3Dプリンティングやマイクロ流体支援薬物カプセル化などの技術改良により、生産はより効率的でカスタマイズ可能になっています。腫瘍科、整形外科、皮膚科などのエンドユーザー分野では、その精度と適応性からハイドロゲルを用いた治療法の採用が増加しています。さらに、人口の高齢化と慢性疾患の蔓延により、長時間作用型の注射システムや移植可能な送達装置に対する需要が高まっています。消費者行動の観点からは、個別化された使いやすいドラッグデリバリーソリューションへの嗜好が高まっており、市場の需要をさらに押し上げています。ラテンアメリカや東南アジアの新興市場でも医療支出が増加しており、ハイドロゲル技術の市場浸透が進んでいます。

セグメント

ポリマー起源（天然、合成、ハイブリッド）、投与経路（皮下、眼、口腔、局所、その他）

調査対象企業の例

  • 3M Company
  • AD Surgical
  • Aquestive Therapeutics Inc.
  • ARx LLC
  • Ashland
  • AstraZeneca Plc.
  • Bausch & Lomb
  • BioDelivery Sciences International Inc.
  • Blairex Laboratories Inc.
  • Coloplast A/S
  • Ferring B.V.
  • Johnson & Johnson
  • Medtronic
  • Micropore Technologies
  • Neurelis, Inc.
  • Ocular Therapeutix, Inc.
  • Pfizer, Inc.
  • ProLynx Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar Pharmaceuticals, Inc.

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31492

Global Hydrogel-based Drug Delivery Systems Market to Reach US$21.6 Billion by 2030

The global market for Hydrogel-based Drug Delivery Systems estimated at US$15.3 Billion in the year 2024, is expected to reach US$21.6 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Natural, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the Synthetic segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 9.3% CAGR

The Hydrogel-based Drug Delivery Systems market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Hydrogel-Based Drug Delivery Systems Market - Key Trends & Drivers Summarized

What Makes Hydrogel-Based Systems a Game-Changer in Modern Drug Delivery?

Hydrogel-based drug delivery systems have emerged as a cornerstone in the evolution of precision medicine, offering an advanced platform for controlled and targeted therapeutic delivery. These hydrophilic polymer networks are prized for their biocompatibility, high water content, and tunable physical properties, which mimic natural tissue environments. A key differentiator lies in their capacity to respond to various physiological stimuli-such as pH, temperature, and enzymes-allowing for site-specific drug release and enhanced therapeutic efficacy. Over recent years, novel hydrogel formulations such as smart hydrogels and nanocomposite hydrogels have been engineered to improve drug retention time and responsiveness, especially in oncological, ophthalmic, and wound care applications. This innovation-driven sector is reshaping treatment paradigms, offering personalized, minimally invasive, and efficient therapeutic options.

Is Innovation the Catalyst Behind the Surge in Biomedical Applications?

Hydrogels have found extensive utility across a wide spectrum of medical applications beyond drug delivery, reinforcing their strategic value in the healthcare sector. Their use in tissue engineering scaffolds, regenerative medicine, and diagnostic systems highlights their versatility. In particular, injectable hydrogels are revolutionizing post-surgical recovery and chronic disease management by providing localized, sustained drug delivery with minimal systemic exposure. This advancement is notably evident in cancer therapeutics, where hydrogels facilitate the direct delivery of chemotherapeutic agents to tumor sites, reducing toxicity. Additionally, the integration of hydrogel technologies with bioelectronic devices is enabling real-time therapeutic feedback systems, creating a bridge between diagnostics and therapy in personalized medicine. Such cross-disciplinary applications are pushing hydrogel technologies into the mainstream of medical innovation.

How Are Regulatory and Research Ecosystems Shaping Market Trajectories?

Supportive regulatory pathways and robust research initiatives are significantly accelerating the commercial viability of hydrogel-based drug delivery systems. Governments and academic institutions globally are increasingly investing in R&D to improve hydrogel formulations and explore their synergistic use with biologics, peptides, and gene therapies. The FDA’s flexible stance on biomaterial approvals has further paved the way for startups and pharma giants alike to bring novel hydrogel systems to market with reduced lead times. Moreover, patent activity in this domain is on the rise, with a strong pipeline of hydrogel-enabled therapeutics under clinical investigation. In parallel, academic-industry collaborations are fostering innovation ecosystems, particularly in North America and Asia-Pacific, which are becoming hotspots for advanced hydrogel technology development. These factors are not only enhancing product pipelines but are also driving down costs through process optimization and scalability.

Why Is Market Expansion Accelerating Across Multiple Therapeutic Frontiers?

The growth in the hydrogel-based drug delivery systems market is driven by several factors that reflect a convergence of technological advances, expanding end-use cases, and shifting consumer expectations. The rising demand for patient-centric, non-invasive treatment modalities is aligning with hydrogel capabilities in localized and sustained drug administration. Technological improvements such as 3D printing of hydrogel matrices and microfluidic-assisted drug encapsulation are making production more efficient and customizable. End-user sectors like oncology, orthopedics, and dermatology are increasingly adopting hydrogel-based therapies due to their precision and adaptability. Additionally, aging populations and the prevalence of chronic diseases are increasing the demand for long-acting injectable systems and implantable delivery devices. From a consumer behavior standpoint, there is a growing preference for personalized, easy-to-use drug delivery solutions, further propelling market demand. Emerging markets in Latin America and Southeast Asia are also witnessing a rise in healthcare spending, enabling broader market penetration of hydrogel technologies.

SCOPE OF STUDY:

The report analyzes the Hydrogel-based Drug Delivery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Polymer Origin (Natural, Synthetic, Hybrid); Administration Route (Subcutaneous, Ocular, Oral Cavity, Topical, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • 3M Company
  • AD Surgical
  • Aquestive Therapeutics Inc.
  • ARx LLC
  • Ashland
  • AstraZeneca Plc.
  • Bausch & Lomb
  • BioDelivery Sciences International Inc.
  • Blairex Laboratories Inc.
  • Coloplast A/S
  • Ferring B.V.
  • Johnson & Johnson
  • Medtronic
  • Micropore Technologies
  • Neurelis, Inc.
  • Ocular Therapeutix, Inc.
  • Pfizer, Inc.
  • ProLynx Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar Pharmaceuticals, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Hydrogel-based Drug Delivery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surging Demand for Targeted and Controlled Drug Delivery Spurs Growth in Hydrogel-based Systems
    • Growing Prevalence of Chronic Diseases Strengthens Business Case for Long-Acting Drug Delivery Platforms
    • Advancements in Biocompatible Materials Expand Addressable Market Opportunity for Hydrogel-based Formulations
    • Increasing R&D Investment by Pharmaceutical Companies Drives Innovation in Hydrogel-based Therapeutics
    • Rising Adoption of Personalized Medicine Accelerates Demand for Tunable Hydrogel Carriers
    • Expansion of Biologics and Peptide Drug Pipeline Spurs Interest in Hydrogel Delivery Technologies
    • Growing Popularity of Minimally Invasive Therapies Drives Adoption of Injectable Hydrogel Systems
    • Supportive Regulatory Approvals and Fast-Track Designations Sustain Growth Momentum Across Developed Markets
    • Proliferation of 3D Printing in Biomedical Applications Throws the Spotlight on Smart Hydrogels for On-Demand Drug Release
    • Escalating Focus on Patient Compliance and Convenience Generates Demand for Sustained Release Hydrogel Platforms
    • Rising Interest in Nanotechnology Integration Propels Development of Advanced Hydrogel Drug Carriers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hydrogel-based Drug Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Natural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Natural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Natural by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Subcutaneous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ocular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Oral Cavity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Oral Cavity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Oral Cavity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030

IV. COMPETITION